PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VERA vs. SMH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between VERA and SMH is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

VERA vs. SMH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vera Therapeutics, Inc. (VERA) and VanEck Vectors Semiconductor ETF (SMH). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
-27.28%
1.09%
VERA
SMH

Key characteristics

Sharpe Ratio

VERA:

-0.60

SMH:

0.74

Sortino Ratio

VERA:

-0.63

SMH:

1.17

Omega Ratio

VERA:

0.92

SMH:

1.15

Calmar Ratio

VERA:

-0.80

SMH:

1.09

Martin Ratio

VERA:

-1.77

SMH:

2.49

Ulcer Index

VERA:

20.32%

SMH:

10.83%

Daily Std Dev

VERA:

60.06%

SMH:

36.28%

Max Drawdown

VERA:

-84.89%

SMH:

-83.29%

Current Drawdown

VERA:

-42.55%

SMH:

-10.73%

Returns By Period

In the year-to-date period, VERA achieves a -32.42% return, which is significantly lower than SMH's 3.23% return.


VERA

YTD

-32.42%

1M

-15.37%

6M

-27.28%

1Y

-41.67%

5Y*

N/A

10Y*

N/A

SMH

YTD

3.23%

1M

-6.43%

6M

1.09%

1Y

19.61%

5Y*

28.96%

10Y*

25.61%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VERA vs. SMH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VERA
The Risk-Adjusted Performance Rank of VERA is 1212
Overall Rank
The Sharpe Ratio Rank of VERA is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of VERA is 1717
Sortino Ratio Rank
The Omega Ratio Rank of VERA is 1919
Omega Ratio Rank
The Calmar Ratio Rank of VERA is 55
Calmar Ratio Rank
The Martin Ratio Rank of VERA is 22
Martin Ratio Rank

SMH
The Risk-Adjusted Performance Rank of SMH is 3333
Overall Rank
The Sharpe Ratio Rank of SMH is 2929
Sharpe Ratio Rank
The Sortino Ratio Rank of SMH is 2929
Sortino Ratio Rank
The Omega Ratio Rank of SMH is 3232
Omega Ratio Rank
The Calmar Ratio Rank of SMH is 4545
Calmar Ratio Rank
The Martin Ratio Rank of SMH is 2828
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VERA vs. SMH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vera Therapeutics, Inc. (VERA) and VanEck Vectors Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VERA, currently valued at -0.60, compared to the broader market-2.000.002.00-0.600.74
The chart of Sortino ratio for VERA, currently valued at -0.63, compared to the broader market-4.00-2.000.002.004.006.00-0.631.17
The chart of Omega ratio for VERA, currently valued at 0.92, compared to the broader market0.501.001.502.000.921.15
The chart of Calmar ratio for VERA, currently valued at -0.80, compared to the broader market0.002.004.006.00-0.801.09
The chart of Martin ratio for VERA, currently valued at -1.77, compared to the broader market-10.000.0010.0020.0030.00-1.772.49
VERA
SMH

The current VERA Sharpe Ratio is -0.60, which is lower than the SMH Sharpe Ratio of 0.74. The chart below compares the historical Sharpe Ratios of VERA and SMH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.60
0.74
VERA
SMH

Dividends

VERA vs. SMH - Dividend Comparison

VERA has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.43%.


TTM20242023202220212020201920182017201620152014
VERA
Vera Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SMH
VanEck Vectors Semiconductor ETF
0.43%0.44%0.60%1.18%0.51%0.69%1.50%1.88%1.43%0.80%2.14%1.16%

Drawdowns

VERA vs. SMH - Drawdown Comparison

The maximum VERA drawdown since its inception was -84.89%, roughly equal to the maximum SMH drawdown of -83.29%. Use the drawdown chart below to compare losses from any high point for VERA and SMH. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-42.55%
-10.73%
VERA
SMH

Volatility

VERA vs. SMH - Volatility Comparison

Vera Therapeutics, Inc. (VERA) has a higher volatility of 25.75% compared to VanEck Vectors Semiconductor ETF (SMH) at 12.51%. This indicates that VERA's price experiences larger fluctuations and is considered to be riskier than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
25.75%
12.51%
VERA
SMH
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab